Medication Affordability and Patent Integrity Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Medication Affordability and Patent Integrity Act, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Trade, Technology.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section S1: 1. Short title This Act may be cited as the Medication Affordability and Patent Integrity Act.
- Section id562F7FB98F334120975D338CAE3BC41B: 2. Disclosure of information Section 505(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(b)) is amended by adding at the end the following: With...
- Section id67CFDDC20013488281907F9506649D33: 274. Non-disclosure defense to infringement of drug patent A person shall be entitled to a defense under section 282(b) in an action asserting infringement of...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Medication Affordability and Patent Integrity Act, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Trade, Technology
Primary Purpose
This bill, Medication Affordability and Patent Integrity Act, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
ReportedCommittee on Health, Education, Labor, and Pensions. Ordered to be …
Committee on Health, Education, Labor, and Pensions. Hearings held.
Ms. Hassan (for herself and Mr. Hawley) introduced the following …
Read twice and referred to the Committee on Health, Education, …
Introduced in Senate
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_commerce"
- → Secretary of Commerce
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology